What is BTAI's dilution risk score?

BTAI has a latest available DilutionScore record of 65/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BTAI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BTAI?

DilutionWatch tracks 25 SEC filing types for BTAI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BTAI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BTAI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BTAI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BTAI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BTAI Dilution Risk Score: 65/100 (HIGH)

Score Breakdown

📋 Offering Ability

50

💰 Cash Runway

95

📊 Float Risk

25

⚠️ Warrant Exposure

70

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 58%

💰 Capital Raise model 73%

• Critical: only 1.6 months cash remaining

• Active ATM program with $62M remaining capacity

🔄 Reverse Split model est. 45%

• 50-day avg $1.20 approaching $1 threshold

• Only 2 months cash — financial pressure

📜 Warrant Exercise model 40%

• Significant warrants: 28% of shares outstanding

• Elevated warrant risk score (70/100)

🔔 Track BTAI — Get forecast alerts →

Market Data

Market Cap$36.13M

Shares Outstanding31.31M

Float26.40M

Cash$12.84M

Debt$104.45M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 73.9% shares (2026Q1 vs prior)

41 institutional holders · 6.18M shares

#1 MILLENNIUM MANAGEMENT LLC 1.94M shares

#2 ARMISTICE CAPITAL, LLC 1.91M shares

#3 OAKTREE CAPITAL MANAGEMENT LP 723.6K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.21M

Days to Cover9.7

% of Float16.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

4 INSIDER TRANSACTION 2026-03-16

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BTAI Dilution Snapshot

BioXcel Therapeutics, Inc. (BTAI) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $62.5M.
Stored outstanding warrants: 8.6M.
Recent SEC activity tracked for BTAI: 4 on 2026-03-16; 4 on 2026-03-16; 4 on 2026-03-16.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.